317 related articles for article (PubMed ID: 26913373)
1. Reproducibility of R
Santin MD; Didier M; Valabrègue R; Yahia Cherif L; García-Lorenzo D; Loureiro de Sousa P; Bardinet E; Lehéricy S
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26913373
[TBL] [Abstract][Full Text] [Related]
2. High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
Betts MJ; Acosta-Cabronero J; Cardenas-Blanco A; Nestor PJ; Düzel E
Neuroimage; 2016 Sep; 138():43-63. PubMed ID: 27181761
[TBL] [Abstract][Full Text] [Related]
3. MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry.
Sharma SD; Fischer R; Schoennagel BP; Nielsen P; Kooijman H; Yamamura J; Adam G; Bannas P; Hernando D; Reeder SB
Magn Reson Med; 2017 Jul; 78(1):264-270. PubMed ID: 27509836
[TBL] [Abstract][Full Text] [Related]
4. Subcortical gray matter segmentation and voxel-based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis.
Cobzas D; Sun H; Walsh AJ; Lebel RM; Blevins G; Wilman AH
J Magn Reson Imaging; 2015 Dec; 42(6):1601-10. PubMed ID: 25980643
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional quantitative susceptibility mapping from standard fMRI studies.
Sun H; Seres P; Wilman AH
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27687150
[TBL] [Abstract][Full Text] [Related]
6. Joint 2D and 3D phase processing for quantitative susceptibility mapping: application to 2D echo-planar imaging.
Wei H; Zhang Y; Gibbs E; Chen NK; Wang N; Liu C
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26887812
[TBL] [Abstract][Full Text] [Related]
7. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
[TBL] [Abstract][Full Text] [Related]
8. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia.
Ogasawara A; Kakeda S; Watanabe K; Ide S; Ueda I; Murakami Y; Moriya J; Futatsuya K; Sato T; Nakayamada S; Saito K; Tanaka Y; Liu T; Wang Y; Korogi Y
Eur Radiol; 2016 Apr; 26(4):1056-63. PubMed ID: 26228900
[TBL] [Abstract][Full Text] [Related]
10. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects.
Aquino D; Bizzi A; Grisoli M; Garavaglia B; Bruzzone MG; Nardocci N; Savoiardo M; Chiapparini L
Radiology; 2009 Jul; 252(1):165-72. PubMed ID: 19561255
[TBL] [Abstract][Full Text] [Related]
11. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.
Eskreis-Winkler S; Zhang Y; Zhang J; Liu Z; Dimov A; Gupta A; Wang Y
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27906525
[TBL] [Abstract][Full Text] [Related]
12. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T.
Chen Y; Genc O; Poynton CB; Banerjee S; Hess CP; Lupo JM
NMR Biomed; 2022 May; 35(5):e4666. PubMed ID: 35075701
[TBL] [Abstract][Full Text] [Related]
13. Multisite reproducibility of quantitative susceptibility mapping and effective transverse relaxation rate in deep gray matter at 3 T using locally optimized sequences in 24 traveling heads.
Naji N; Lauzon ML; Seres P; Stolz E; Frayne R; Lebel C; Beaulieu C; Wilman AH
NMR Biomed; 2022 Nov; 35(11):e4788. PubMed ID: 35704837
[TBL] [Abstract][Full Text] [Related]
14. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron.
Wisnieff C; Ramanan S; Olesik J; Gauthier S; Wang Y; Pitt D
Magn Reson Med; 2015 Aug; 74(2):564-70. PubMed ID: 25137340
[TBL] [Abstract][Full Text] [Related]
15. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
[TBL] [Abstract][Full Text] [Related]
16. Value of transverse relaxometry difference methods for iron in human brain.
Uddin MN; Lebel RM; Wilman AH
Magn Reson Imaging; 2016 Jan; 34(1):51-9. PubMed ID: 26435459
[TBL] [Abstract][Full Text] [Related]
17. [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping].
Guan JJ; Feng YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):305-311. PubMed ID: 29643036
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
[TBL] [Abstract][Full Text] [Related]
19. MRI assessment of basal ganglia iron deposition in Parkinson's disease.
Wallis LI; Paley MN; Graham JM; Grünewald RA; Wignall EL; Joy HM; Griffiths PD
J Magn Reson Imaging; 2008 Nov; 28(5):1061-7. PubMed ID: 18972346
[TBL] [Abstract][Full Text] [Related]
20. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
